Appropriate utilization of semi-quantitative analysis in salivary scintigraphy

Nuclear Medicine Communications

Volumn 25, Issue 12, 2004, Pages 1203-1210

  Booker, John ^a   Howarth, Douglas ^a   Taylor, Lorraine ^a   Voutnis, Demetrius ^a   Sutherland, David ^a  

^a Hunter Imaging Group   (Australia)

Author keywords

Salivary scintigraphy; Semi quantitative parameters; Sjogren's syndrome; Xerostomia

Indexed keywords

ARTICLE; HEART EJECTION FRACTION; HUMAN; NEUROSECRETION; NORMAL HUMAN; PARAMETER; PAROTID GLAND; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RADIOACTIVITY; SCINTIGRAPHY; SJOEGREN SYNDROME; STATISTICAL SIGNIFICANCE; VOLUNTEER; XEROSTOMIA;

CASE-CONTROL STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PAROTID GLAND; RADIONUCLIDE IMAGING; ROC CURVE; SALIVA; SALIVARY GLAND DISEASES; SALIVARY GLANDS; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; SUBMANDIBULAR GLAND; TIME FACTORS; XEROSTOMIA;

EID: 10144260636     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200412000-00009     Document Type: Article

References (28)

1. Daniels TE. Evaluation, differential diagnosis, and treatment of xerostomia. J Rheumatol 2000; 27(Suppl. 61):6-10.
2. Sreebny LM. Saliva in health and disease: an appraisal and update. Int Dent J 2000; 50:140-161.
3. Sreebny LM, Valdini A. Xerostomia. A neglected symptom. Arch Intern Med 1987; 147:1333-1337.
4. Bergdahl M, Bergdahl J. Low unstimulated salivary flow and subjective oral dryness in association with anxiety, depression, medication and stress. J Dent Res 2000; 79:1652-1658.
5. Allweiss P, Braunstein GD, Katz A, Waxman A. Sialadenitis following I-131 therapy for thyroid carcinoma: concise communication. J Nucl Med 1984; 25:755-758.
6. Arrago JP, Rain JD, Brocheriou C, Rocher F. Scintigraphy of the salivary glands in Sjogren's syndrome. J Clin Pathol 1987; 40:1463-1467.
7. Hakansson U, Jacobsson Lilja B, Manthorpe R. Salivary scintigraphy in subjects with and without symptoms of dry mouth and/or eyes and in patients with primary Sjogren's syndrome. Scand J Rheumatol 1994; 23:326-333.
8. Klutmann S, Bohuslavizki KH, Kroger S, et al. Quantitative salivary gland scintigraphy. J Nucl Med Technol 1999; 27:20-26.
9. Delpassand ES, Zare F, Broussard W, Mathai M, Jacob R, Podoloff DA. Functional ratios of normal salivary glands using dual detector gamma camera and geometric mean. Clin Nucl Med 1997; 22:200.
10. 99mTc-pertechnetate salivary gland scintigraphy in normal subjects. Nucl Med Commun 1997; 18:363-366.
11. Manthorpe R, Oxholm P, Prause JU, Schiodt M. The Copenhagen criteria for Sjogren's syndrome. Scand J Rheumatol 1986; 61(Suppl):19.
12. Bryant TN. Computer software for calculating confidence intervals (CIA). In: Altman DG, (ed.). Statistics with Confidence. Bristol: BMJ; 2002, pp. 208-213.
13. O'Brien PC, Shampo MA, Robertson JS. Statistics for nuclear medicine. Part 3:A. Comparing two proportions (the relative deviate test and chi-square equivalent). B. Counting data. J Nucl Med 1983; 24:269-272.
14. 99mTc. Nucleonics 1964; 22:50-54.
15. Borner W, Grunberg H, Moll E. Die Szintigraphische Darstellung der kopfspeicheldrusen mit Technetium 99-m. Med Welt 1965; 42:2378-2380.
16. Stephen KW, Robertson JWK, Harden R. Quantitative aspects of pertechnetate concentration in human parotid and submandibular glands. Br J Radiol 1976; 49:1028-1032.
17. Harden R, Hilditch TE, Kennedy I, Mason DK, Papadopolous S, Alexander WD. Uptake and scanning of the salivary glands in man using pertechnetate-99m-Tc. Clin Sci 1967; 32:49-55.
18. Lazarus JH, Stephen KW, Harden R, Robertson JWK, Lister G. Simultaneous quantitative measurement of I-131 iodine and 99m-Tc pertechnetate uptake by human salivary glands using scintiscanning with validation by direct estimation in biopsy samples. Eur J Clin Invest 1973; 3:156-159.
19. Van Den Akker HP, Busemann-Sokole E. Sequential scintigraphy of the salivary glands with special reference to the oral activity. Int J Oral Surg 1974; 3:321-325.
20. Van Den Akker HP, Busemann-Sokole E, van den Schoot JB. Origin and location of the oral activity in sequential salivary scintigraphy with 99m Tc-pertechnetate. J Nucl Med 1976; 17:959-964.
21. Schall GL, Anderson LG, Wolf RO, et al. Xerostomia in Sjogren's syndrome. Evaluation by serial salivary scintigraphy. J Am Med Assoc 1971; 216:2109-2116.
22. Hermann GA, Vivino FB, Shnier D, Krumm R, Mayrin V. Diagnostic accuracy of salivary scintigraphic indices in xerostomic populations. Clin Nucl Med 1999; 24:167-172.
23. Umehara I, Yamada I, Murata Y, Takahashi Y, Okada N, Shibuya H. Quantitative evaluation of salivary gland scintigraphy in Sjogren's syndrome. J Nucl Med 1999; 40:64-69.
24. Aung W, Murata Y, Ishida R, Takahashi Y, Okada N, Shibuya H. Study of quantitative oral radioactivity in salivary gland scintigraphy and determination of the clinical stage of Sjogren's syndrome. J Nucl Med 2001; 42:38-43.
25. Adams BK, Al Attia HM, Parkar S. Salivary scintigraphy in Sjogren's syndrome: are quantitative indices the answer? Nucl Med Commun 2003; 24:1011-1016.
26. Hermann GA, Vivino FB, Shnier D, Krumm R, Mayrin V, Shore J. Variability of quantitative scintigraphic salivary indices in normal subjects. J Nucl Med 1998; 39:1260-1263.
27. Scott J, Cawood JI, Grime JS, Critchley M, Jones RS. Histological evaluation of quantitative scintigraphy of the salivary glands in a primate model. Int J Oral Surg 1984; 13:45-52.
28. Fox RI, Stern M, Michelson P. Update in Sjogren's syndrome. Curr Opin Rheumatol 2000; 12:391-398.